• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action.

作者信息

Heerspink Hiddo Jl, Cherney David Zi, Groop Per-Henrik, Matthieu Chantal, Rossing Peter, Tuttle Katherine R, McGill Janet B

机构信息

Department of Clinical Pharmacy and Pharmacology, University of Groningen, 9700 RB Groningen, Netherlands; The George Institute for Global Health, Sydney, NSW, Australia.

University of Toronto, ON, Canada.

出版信息

Lancet Diabetes Endocrinol. 2023 Aug;11(8):536-540. doi: 10.1016/S2213-8587(23)00168-7. Epub 2023 Jun 23.

DOI:10.1016/S2213-8587(23)00168-7
PMID:37364589
Abstract
摘要

相似文献

1
People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action.1型糖尿病和慢性肾病患者迫切需要新的治疗方法：行动呼吁。
Lancet Diabetes Endocrinol. 2023 Aug;11(8):536-540. doi: 10.1016/S2213-8587(23)00168-7. Epub 2023 Jun 23.
2
Preventing kidney failure in people with diabetes.预防糖尿病患者的肾衰竭。
Diabet Med. 2014 Nov;31(11):1280-3. doi: 10.1111/dme.12535.
3
Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care.糖尿病和慢性肾脏病：一种日益常见的多病共存疾病，需要在治疗模式上进行转变。
Diabet Med. 2018 Mar;35(3):300-305. doi: 10.1111/dme.13564. Epub 2018 Jan 8.
4
Tactics to prevent or slow progression of CKD in patients with diabetes.预防或延缓糖尿病患者 CKD 进展的策略。
J Fam Pract. 2021 Jan-Feb;70(1):6-12. doi: 10.12788/jfp.0126.
5
SGLT2 Inhibitors in Diabetic Kidney Disease.糖尿病肾病中的钠-葡萄糖协同转运蛋白2抑制剂
Clin J Am Soc Nephrol. 2021 Apr 7;16(4):631-633. doi: 10.2215/CJN.18881220. Epub 2021 Feb 3.
6
New insights of cardiovascular and renal protection in diabetic chronic kidney disease with finerenone.非奈利酮对糖尿病慢性肾脏病心血管和肾脏保护的新见解
Cardiovasc Res. 2022 Mar 25;118(5):e36-e37. doi: 10.1093/cvr/cvac024.
7
Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL.糖尿病和慢性肾脏病患者的自我管理与健康相关生活质量的逐步改善有关。
J Diabetes Complications. 2017 Feb;31(2):427-432. doi: 10.1016/j.jdiacomp.2016.10.027. Epub 2016 Oct 29.
8
Renal Rules. Your guide to understanding and preventing kidney disease.肾脏规则。助您了解和预防肾脏疾病的指南。
Diabetes Forecast. 2016 Mar-Apr;69(2):28-9.
9
[Current guidelines for the prevention and treatment of diabetic nephropathy. International Diabetes Federation].[糖尿病肾病防治的现行指南。国际糖尿病联盟]
Ned Tijdschr Geneeskd. 1995 Sep 9;139(36):1847-9.
10
Diabetes and chronic kidney disease: concern, confusion, clarity?糖尿病与慢性肾脏病：担忧、困惑、明晰？
Can J Diabetes. 2014 Oct;38(5):287-9. doi: 10.1016/j.jcjd.2014.08.001.

引用本文的文献

1
Finerenone in type 1 diabetes and chronic kidney disease: short-term efficacy and safety insights.非奈利酮治疗1型糖尿病和慢性肾脏病：短期疗效与安全性观察
Int Urol Nephrol. 2025 Sep 5. doi: 10.1007/s11255-025-04773-y.
2
Prevalence and severity of chronic kidney disease in a population with type 1 diabetes from a United States health system: a real-world cohort study.美国医疗系统中1型糖尿病患者群体的慢性肾脏病患病率及严重程度：一项真实世界队列研究。
Lancet Reg Health Am. 2025 May 15;47:101130. doi: 10.1016/j.lana.2025.101130. eCollection 2025 Jul.
3
Epidemiological trends and risk factors of CKD-T1DM in children and adolescents across 204 countries and territories (1990-2021).
1990年至2021年期间204个国家和地区儿童及青少年慢性肾脏病合并1型糖尿病的流行病学趋势及危险因素
Front Endocrinol (Lausanne). 2025 Mar 26;16:1551467. doi: 10.3389/fendo.2025.1551467. eCollection 2025.
4
Global Burden of Type 1 Diabetes Mellitus Related Chronic Kidney Disease among Adolescents and Young Adults, and Projections to 2035: Results from the Global Burden of Disease Study 2021.青少年和青年中1型糖尿病相关慢性肾脏病的全球负担及到2035年的预测：全球疾病负担研究2021的结果
Diabetes Metab J. 2025 Jul;49(4):812-825. doi: 10.4093/dmj.2024.0544. Epub 2025 Mar 10.
5
Extending Kidney Protective Therapy to Type 1 Diabetes: The Time is Now.将肾脏保护疗法扩展至1型糖尿病：时机已至。
Clin J Am Soc Nephrol. 2025 Apr 1;20(4):474-476. doi: 10.2215/CJN.0000000685. Epub 2025 Mar 12.
6
Endothelin receptor antagonists in chronic kidney disease.慢性肾脏病中的内皮素受体拮抗剂
Nat Rev Nephrol. 2025 Mar;21(3):175-188. doi: 10.1038/s41581-024-00908-z. Epub 2024 Dec 6.
7
Attenuated kidney oxidative metabolism in young adults with type 1 diabetes.1型糖尿病青年成人的肾脏氧化代谢减弱
J Clin Invest. 2024 Oct 22;134(24):e183984. doi: 10.1172/JCI183984.
8
Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus.白蛋白尿和肾功能快速下降作为1型糖尿病肾脏临床试验的入选标准。
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):62-71. doi: 10.2215/CJN.0000000000000567. Epub 2024 Nov 18.
9
Adiposity in Chinese people with type 1 diabetes.1型糖尿病中国患者的肥胖问题。
World J Diabetes. 2024 Jul 15;15(7):1404-1408. doi: 10.4239/wjd.v15.i7.1404.
10
Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S.美国成人 1 型糖尿病患者慢性肾脏病的患病率
Diabetes Care. 2024 Aug 1;47(8):1395-1399. doi: 10.2337/dc24-0335.